Peijia Medical Limited

9996

KYG6981F1090

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 08:08:22 16/03/2026 GMT			5-day change	1st Jan Change
5.760 ^HKD	+1.05%		-3.19%	-4.16%

02-09	Peijia Medical Files for EU Approval of Heart Implant	MT
02-06	Peijia Medical Anticipates Rise in 2025 Revenue	MT

Peijia Medical Files for EU Approval of Heart Implant

Published on 02/09/2026 at 01:32 am GMT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Peijia Medical Limited

02-09	Peijia Medical Files for EU Approval of Heart Implant	MT
02-06	Peijia Medical Anticipates Rise in 2025 Revenue	MT
02-06	Peijia Medical posts Jan to Dec unaudited revenue of RMB700 million-RMB720 million	RE
02-05	Peijia Medical Limited Provides Revenue Guidance for Year Ended December 31, 2025	CI
12-11	Peijia Medical receives NMPA approval for Taurus Trio Tav system	RE
12-11	Peijia Medical Limited Receives Approval from the National Medical Products Administration of the People's Republic of China for the Registration Application of the TaurusTrioTM Transcatheter Aortic Valve System	CI
12-08	Peijia Medical Medical Device Accepted for Review in China	MT
12-08	Peijia Medical Chairman/CEO Boosts Stake; Shares Rise 6%	MT
12-07	Peijia Medical Limited Receives Confirmation Letter from the National Medical Products Administration of the People's Republic of China	CI
12-05	Peijia Medical's CEO bought shares of co since Dec 1	RE
10/10/25	Peijia Medical's Registration Application for GeminiOne Transcatheter Accepted in China	MT
10/10/25	Peijia Medical says Geminione TEER system registration accepted by NMPA	RE
10/10/25	Peijia Medical Limited Confirms the Acceptance of the Registration Application for the GeminiOne Transcatheter Edge-To-Edge Repair System	CI
26/09/25	Peijia Medical Enrolls, Treats First Patient in Transcatheter Aortic Valve Replacement System Trial	MT
26/09/25	Peijia Medical Limited Announces First Patient Treatment in Multi-Center Registration Clinical Trial of ReachTile Robotic-Assisted TAVR System	CI

Peijia Medical Ltd is a China-based holding company mainly engaged in the research and development of interventional procedural medical devices. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The Company's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The Company operates its businesses primarily in domestic market.

Employees

1,035

Sector

Medical Equipment, Supplies & Distribution

Calendar

03-25 - Earnings release - Annual 2025

More about the company